Lukas R C Dekker
Overview
Explore the profile of Lukas R C Dekker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Riva M, Evertz R, Lukac P, Dekker L, Blaauw Y, Ter Bekke R, et al.
Europace
. 2025 Feb;
27(2).
PMID: 39992165
Aims: The optimal substrate ablation approach for post-myocardial infarction (MI) ventricular tachycardia (VT) is unknown. Proposed ablation targets are prone to individual interpretation making the ablation outcome potentially operator dependent....
2.
Vermeer J, van den Broek J, Dekker L
Int J Cardiol Cardiovasc Risk Prev
. 2024 Nov;
23:200344.
PMID: 39534719
Both the development and progression of atrial fibrillation (AF) are affected by a range of modifiable lifestyle risk factors. These key modifiable risk factors encompass obesity, hypertension, hypercholesterolemia, diabetes mellitus,...
3.
Eversdijk M, Habibovic M, Willems D, Kop W, Ploem M, Dekker L, et al.
Circ Arrhythm Electrophysiol
. 2024 Aug;
17(9):e012913.
PMID: 39171393
Out-of-hospital cardiac arrest is a major health problem, and immediate treatment is essential for improving the chances of survival. The development of technological solutions to detect out-of-hospital cardiac arrest and...
4.
van den Broek J, Gottlieb L, Vermeer J, Overeem S, Dekker L
JACC Clin Electrophysiol
. 2024 Aug;
10(8):1916-1928.
PMID: 39093277
Within the broad spectrum of atrial fibrillation (AF) symptomatology, there is a striking subset of patients with predominant or even solitary nocturnal onset of the arrhythmia. This review covers AF...
5.
van de Kar M, van Brakel T, Vant Veer M, van Steenbergen G, Daeter E, Crijns H, et al.
Eur Heart J
. 2024 May;
45(29):2620-2630.
PMID: 38809189
Background And Aims: This study aimed to evaluate clinical outcomes in patients developing post-operative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) and characterize variations in oral anticoagulation (OAC)...
6.
Willems E, Janssens K, Dekker L, van de Vosse F, Cluitmans M, Bovendeerd P
Front Physiol
. 2024 Apr;
15:1330157.
PMID: 38655031
Assessing a patient's risk of scar-based ventricular tachycardia (VT) after myocardial infarction is a challenging task. It can take months to years after infarction for VT to occur. Also, if...
7.
Montree R, Peri E, Haakma R, Dekker L, Vullings R
Physiol Meas
. 2024 Feb;
45(3).
PMID: 38387047
Wearable devices that measure vital signals using photoplethysmography are becoming more commonplace. To reduce battery consumption, computational complexity, memory footprint or transmission bandwidth, companies of commercial wearable technologies are often...
8.
Hup R, Linssen E, Eversdijk M, Verbruggen B, Bak M, Habibovic M, et al.
Resusc Plus
. 2024 Feb;
17:100576.
PMID: 38370313
Aim: Out-of-hospital cardiac arrest is a major health problem, and the overall survival rate is low (4.6%-16.4%). The initiation of the current chain of survival depends on the presence of...
9.
Demandt J, Koks A, Sagel D, van Hattem V, Haest R, Heijmen E, et al.
Heart
. 2023 Dec;
110(6):408-415.
PMID: 38040452
Objective: Prehospital risk stratification and triage are currently not performed in patients suspected of non-ST-segment elevation acute coronary syndrome (NSTE-ACS). This may lead to prolonged time to revascularisation, increased duration...
10.
Gottlieb L, Dekker L, Coronel R
Front Physiol
. 2023 Jun;
14:1157338.
PMID: 37293260
Atrial fibrillation (AF) often requires invasive treatment by ablation to decrease symptom burden. The pulmonary veins (PV) are thought to trigger paroxysms of AF, and ablative PV isolation (PVI) is...